bioRxivMicrobiology
Integration in or Near Oncogenes Plays Only a Minor Role in Determining the in Vivo Distribution of HIV Integration Sites Before or During Suppressive Antiretroviral Therapy
J. M. Coffin, M. Bale, D. Wells, S. Guo, B. Luke, J. M. Zerbato, M. D. Sobolewski, T. Sia, W. Shao, X. Wu, F. Maldarelli, M. F. Kearney, J. W. Mellors, S. H. Hughes
Abstract
HIV persists during antiretroviral therapy (ART) as integrated proviruses in cells descended from a small fraction of the CD4+ T cells infected prior to the initiation of ART. To better understand what controls HIV persistence and the distribution of integration sites (IS), we compared about 16,000 and 54,000 IS from individuals pre-ART and on ART, respectively, with approximately 385,000 IS from PBMC infected in vitro. The distribution of IS in vivo is quite similar to the distribution in PBMC, modified by selection against proviruses in expressed genes, by selection for proviruses integrated into one of 6 specific genes, and by clonal expansion. The clones in which a provirus integrated in an oncogene contributed to the survival of the clone comprise only a small fraction of the clones that persist in HIV-infected individuals on ART. Mechanisms that do not involve the provirus, or its location in the host genome, are more important in determining which clones expand and persist. Author SummaryIn HIV-infected individuals, a small fraction of the infected cells persist and divide. This reservoir persists on ART and can rekindle the infection if ART is discontinued. Because the number of possible sites of HIV DNA integration is very large, each infected cell, and all of its descendants, can be identified by the site where the provirus is integrated (IS). To understand the selective forces that determine the fates of infected cells in vivo, we compared the distribution of HIV IS in freshly-infected cells to cells from HIV-infected donors sampled both before and during ART. We found that, as has been previously reported, integration favors highly-expressed genes. However, over time the fraction of cells with proviruses integrated in highly-expressed genes decreases, implying that they grow less well. There are exceptions to this broad negative selection. When a provirus is integrated in a specific region in one of six genes, the proviruses affect the expression of the target gene, promoting growth and/or survival of the cell. Although this effect is striking, it is only a minor component of the forces that promote the growth and survival of the population of infected cells during ART.
- organism: human
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
D. B. Reeves, E. R. Duke, … J. T. Schiffer·bioRxiv·Sep 7, 2018
- Early Emergence and Long-Term Persistence of HIV-Infected T Cell Clones in Children
M. J. Bale, M. G. Katusiime, … M. F. Kearney·bioRxiv·Sep 15, 2020
- Proviral sequencing suggests the majority of the HIV reservoir is expressed over time but significant decay is obscured by clonal expansion
Marilia Rita Pinzone, D. Jake VanBelzen, … Una O’Doherty·bioRxiv·Jun 15, 2018
- Transcription of HIV-1 at sites of intact latent provirus integration
Ana Rafaela Teixeira, Cíntia Bittar, … Michel C. Nussenzweig·The Journal of Experimental MedicinePeer-reviewed·Jul 31, 2024
- Selective clonal persistence of human retroviruses in vivo: radial chromatin organization, integration site and host transcription
A. Melamed, T. W. Fitzgerald, … C. R. M. Bangham·bioRxiv·Nov 10, 2021
- Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis
D. F. Read, E. Atindaana, … J. M. Kidd·PLOS PathogensPeer-reviewed·Oct 4, 2019